Report copyright - Q2 REPORT 2016 - Cisionmb.cision.com/Main/14266/2305554/698849.pdfFinancial review Q2 Key Therapeutic Areas Revenue was SEK 1,076 M (398). Inflammation EU where drugs are immediately
Please pass captcha verification before submit form